Development of monoclonal antibody therapeutics for alzheimer's disease

Background: In a previous review article in the Taiwanese Journal of Psychiatry (Takeda and Tagami: Taiwanese J. Psychiatry 2020; 34: 152-61), we gave the development status of drugs for Alzheimer's disease, presented a relatively pessimistic view, and highlighted the difficulties in their deve...

Full description

Bibliographic Details
Main Author: Masatoshi Takeda
Format: Article
Language:English
Published: Wolters Kluwer Medknow Publications 2022-01-01
Series:Taiwanese Journal of Psychiatry
Subjects:
Online Access:http://www.e-tjp.org/article.asp?issn=1028-3684;year=2022;volume=36;issue=4;spage=148;epage=156;aulast=Takeda